12-Oct-2026 14:04:43
LALPATHLABAcquisition and merger
LALPATHLAB: NCT DELHI SUBSIDIARY ACQUIRES 100% EQUITY OF CENTRAPATH LABS
• Dr Lal PathLabs to subscribe to equity shares of PathLabs Unifiers Private Limited (PUPL), its wholly owned subsidiary, for up to ₹30.3 Cr • Investment will fund PUPL's acquisition of the remaining 30% equity stake in CentraPath Labs Private Limited (CPL) • Post acquisition, CPL will become a wholly owned subsidiary of PUPL; transaction marked completed
Dr. Lal PathLabs Ltd
Open attachment